SICILIANO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 55.804
AS - Asia 23.412
EU - Europa 20.467
SA - Sud America 3.805
AF - Africa 1.217
Continente sconosciuto - Info sul continente non disponibili 1.077
OC - Oceania 98
Totale 105.880
Nazione #
US - Stati Uniti d'America 52.107
IT - Italia 8.322
SG - Singapore 7.468
CN - Cina 6.525
HK - Hong Kong 3.831
CA - Canada 3.320
BR - Brasile 3.154
SE - Svezia 2.600
DE - Germania 2.269
VN - Vietnam 1.954
BG - Bulgaria 1.469
GB - Regno Unito 1.107
TR - Turchia 1.012
FR - Francia 863
FI - Finlandia 849
RU - Federazione Russa 730
UA - Ucraina 626
IN - India 534
CI - Costa d'Avorio 503
KR - Corea 433
AT - Austria 391
JP - Giappone 361
CH - Svizzera 302
BD - Bangladesh 237
NL - Olanda 229
AR - Argentina 195
MX - Messico 178
IQ - Iraq 170
SN - Senegal 141
ES - Italia 133
ZA - Sudafrica 130
NG - Nigeria 129
PL - Polonia 124
BE - Belgio 106
ID - Indonesia 98
EC - Ecuador 94
PK - Pakistan 90
VE - Venezuela 88
SA - Arabia Saudita 84
IL - Israele 77
UZ - Uzbekistan 76
CO - Colombia 70
MA - Marocco 66
PH - Filippine 62
CL - Cile 52
AU - Australia 50
CZ - Repubblica Ceca 50
KE - Kenya 47
NZ - Nuova Zelanda 47
UY - Uruguay 46
EG - Egitto 43
PY - Paraguay 43
IE - Irlanda 42
PE - Perù 40
MY - Malesia 38
AE - Emirati Arabi Uniti 37
JM - Giamaica 34
TN - Tunisia 34
IR - Iran 33
LT - Lituania 33
NP - Nepal 33
GR - Grecia 32
JO - Giordania 31
AZ - Azerbaigian 30
CR - Costa Rica 29
BJ - Benin 26
HU - Ungheria 25
KZ - Kazakistan 25
OM - Oman 25
PA - Panama 24
DZ - Algeria 21
RO - Romania 21
DK - Danimarca 20
ET - Etiopia 20
DO - Repubblica Dominicana 19
HN - Honduras 19
PT - Portogallo 19
TW - Taiwan 19
BO - Bolivia 17
AL - Albania 16
LB - Libano 16
NI - Nicaragua 16
GT - Guatemala 14
KG - Kirghizistan 14
TH - Thailandia 14
TT - Trinidad e Tobago 14
PS - Palestinian Territory 12
RS - Serbia 12
BH - Bahrain 11
GE - Georgia 11
LV - Lettonia 11
AO - Angola 10
LY - Libia 10
AM - Armenia 9
BA - Bosnia-Erzegovina 9
BB - Barbados 8
EE - Estonia 8
HR - Croazia 8
SK - Slovacchia (Repubblica Slovacca) 8
EU - Europa 7
Totale 104.669
Città #
Woodbridge 5.592
Ashburn 5.128
Singapore 4.169
Houston 3.812
Fairfield 3.781
Hong Kong 3.764
Ann Arbor 3.390
San Jose 2.772
Chandler 2.762
Dallas 2.671
Santa Clara 2.548
Montreal 2.366
Seattle 1.774
Milan 1.614
Sofia 1.465
Shanghai 1.456
Beijing 1.360
Wilmington 1.334
Serra 1.314
Cambridge 1.273
New York 1.130
Jacksonville 798
Boardman 757
Ottawa 749
Los Angeles 691
Princeton 666
Izmir 626
Lawrence 593
Medford 553
Hefei 545
Lauterbourg 540
Abidjan 503
Council Bluffs 486
Ho Chi Minh City 478
Florence 459
Rome 434
Nanjing 431
Seoul 418
Vienna 334
Des Moines 332
Munich 330
Tokyo 326
Hanoi 313
Frankfurt am Main 303
Buffalo 274
Istanbul 268
Pisa 251
São Paulo 242
Redondo Beach 236
London 235
Bern 233
Dong Ket 226
San Diego 214
Columbus 202
The Dalles 202
Dearborn 188
Nanchang 187
Helsinki 179
Ogden 170
Turku 163
Jüchen 151
Bremen 142
Dakar 140
Redwood City 135
Orem 133
Lagos 125
Chicago 117
Rio de Janeiro 109
Kunming 106
Lancaster 102
Norwalk 100
Warsaw 100
Hebei 93
Shenyang 93
Changsha 92
Brussels 89
Belo Horizonte 86
Düsseldorf 86
Fuzhou 78
Pune 78
Da Nang 75
Naples 74
Brooklyn 73
Atlanta 69
Livorno 69
Phoenix 69
San Francisco 69
Tashkent 69
Nuremberg 68
Tianjin 68
Toronto 66
Baghdad 65
Washington 65
Boulder 63
Guangzhou 63
Chennai 62
Falls Church 61
Jiaxing 60
Johannesburg 60
Dhaka 56
Totale 74.089
Nome #
Stima della prevalenza della sclerosi laterale amiotrofica (SLA): elaborazione di un algoritmo dai dati sanitari routinari 2.640
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.545
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 780
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 498
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 352
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 310
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 297
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 280
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 276
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 273
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 273
Dream recall in patients with focal cerebral lesions. 252
Mozart’s music between predictability and surprise: results of an experimental research based on electroencephalography, entropy and Hurst exponent 252
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 248
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 247
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 245
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 244
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 240
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 240
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 239
Dysphagia in Amyotrophic Lateral Sclerosis: relationshisp between disease progression and fiberoptic endoscopic evaluation of swallowing. 239
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 236
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 233
Antimyoclonic effect of levetiracetam in MERRF syndrome 232
Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children 232
Metabolic myopathies: functional evaluation by different exercise testing approaches 232
Progressive sensorineural hearing loss in childhood 232
The role of mitochondria in stem cell biology 231
Mitochondrial DNA-related disorders 229
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 229
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 228
Tetracycline treatment in patients with progressive external ophthalmoplegia. 228
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? 226
Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. 224
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 224
Clinical Trials for Neuroprotection in ALS 224
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 224
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 223
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 223
Effects of anticholinergic agents on the excitability of the blink reflex in Meige syndrome. 222
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 221
Pain threshold and polysynaptic components of the blink reflex in Parkinson's disease. 220
Thyroid function and oral TRH in amyotrophic lateral sclerosis 220
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 220
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 220
Detecting the vulnerable carotid plaque: the Carotid Artery Multimodality imaging Prognostic study design 218
Oxidative stress modulation in neurodegenerative diseases 217
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 217
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. 215
Mitochondria, cognitive impairment, and Alzheimer's disease. 215
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 214
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 214
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals 213
Dream recall after sleep interruption in brain-injured patients. 213
An atypical presentation of sporadic adult-onset centronuclear myopathy 213
A case of pelvic floor myoclonic jerk syndrome. 212
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 211
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 211
High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis 211
Risk factors for CIDP: antecedent events, lifestyle and dietary habits. Data from the Italian CIDP database 211
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis 209
Tarsal tunnel syndrome in seronegative spondyloarthropathy. 208
A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia. 208
Evidence of increased restless legs syndrome occurrence in chronic and highly disabling migraine 208
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 206
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 206
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 206
Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study 205
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature 205
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 205
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 205
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 204
Inflammatory myopathy in a patient with postural and kinetik tremor. 204
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 204
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 204
Physical exercise and oxidative stress in muscular dystrophies: is there a good balance? Exercise and oxidative stress in MDs 204
Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature. 204
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 203
Quantitative evaluations of systemic and neuromuscular modifications induced by specific training in sedentary subjects 202
Reply to P.M. Foye ( Letter ) 202
The hOGG1 Ser326Cys polymorphism and Huntington's disease 202
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. 202
A STANDARDIZED CLINICAL EVALUATION OF PATIENTS AFFECTED BY FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: THE FSHD CLINICAL SCORE 201
Mitochondria and neurodegeneration 200
Psychiatric involvement in adult patients with mitochondrial disease. 200
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 199
Astrocyte-neuron interactions in neurological disorders 199
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 198
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 198
Brain MRI in Monogenic Cerebral Small Vessel Diseases: A Practical Handbook 198
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. 197
The Role of Mitochondria in StemCell Biology 196
Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone 196
A personal monitoring architecture to detect muscular fatigue in elderly. 196
Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients 195
Mitochondrial DNA single deletion in a patient with postural tremor. 194
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 194
Congenital myopathies: Clinical phenotypes and new diagnostic tools 194
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 194
Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia 193
Totale 27.656
Categoria #
all - tutte 294.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 294.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.448 0 390 182 434 1.180 842 183 403 308 218 486 1.822
2022/20239.121 952 1.135 599 811 1.022 1.065 117 670 1.645 106 806 193
2023/20249.919 843 779 878 512 1.050 1.247 400 261 177 2.569 441 762
2024/202521.126 193 815 322 1.256 1.976 2.063 1.934 1.235 2.124 2.641 2.300 4.267
2025/202623.990 1.643 2.955 2.986 2.057 2.344 2.119 3.557 1.184 1.220 2.040 1.390 495
2026/20271.119 681 438 0 0 0 0 0 0 0 0 0 0
Totale 105.880